C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
12/2006
12/20/2006	CN1882572A Quinazoline derivatives as antitumor agents
12/20/2006	CN1882549A 7-phenylalkyl substituted 2-quinolinones and 2 quinoxalinones as poly(adp-ribose) polymerase inhibitors
12/20/2006	CN1882547A 6-alkenyl and 6-phenylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(adp-ribose) polymerase inhibitors
12/20/2006	CN1882540A Derivatives of n-phenyl(piperidine-2-yl)methyl benzamide, preparation method thereof and applications of same in therapeutics
12/20/2006	CN1882537A Substituted indole acid derivatives and their use as PAI-1 inhibitors
12/20/2006	CN1882532A Aminoalkylamide substituted cyclohexyl derivatives
12/20/2006	CN1882332A Dual alanyl aminopeptidase and dipeptidyl peptidase iv inhibitors for functionally influencing different cells and for treating immunological, inflammatory, neuronal and other diseases
12/20/2006	CN1880304A Triamide-substituted indoles, benzofuranes and benzothiophenes
12/20/2006	CN1290844C Dihydro Indolinone derivatives used as protein kinase inhibitor
12/19/2006	US7151175 Propenecarboxylic acid amidoxime derivatives, a process for the preparation thereof, and pharmaceutical compositions containing the same
12/19/2006	US7151115 Diphenylmethyl compounds useful as muscarinic receptor antagonists
12/19/2006	US7151113 Pyrazole-amine compounds useful as kinase inhibitors
12/19/2006	US7151102 Phthalazinone derivatives
12/19/2006	US7151101 For prevention/treatment of cancer, inflammatory diseases, autoimmune diseases, destructive bone disorders, proliferative disorders, infectious diseases, viral diseases and neurodegenerative diseases
12/19/2006	US7151098 Glutamate receptor antagonists
12/19/2006	CA2259538C Compounds having antihypertensive, cardioprotective, anti-ischemic and antilipolytic properties
12/14/2006	WO2006133426A2 Compositions and methods for inhibition of the jak pathway
12/14/2006	WO2006133326A1 Inhibitors of hcv replication
12/14/2006	WO2006132594A1 Novel dipodazine compounds and applications
12/14/2006	WO2006131835A2 Heterocyclic triazines as hypoxic selective protein kinase inhibitors
12/14/2006	WO2006131632A1 Hydrates of alkaline-earth salts of irbesartan and the preparation thereof
12/14/2006	WO2006131340A2 Pyrrolones that act as peptide deformylase (pdf) inhibitors
12/14/2006	WO2006131303A2 Peptide deformylase (pdf) inhibitors 4
12/14/2006	WO2006131192A1 New materials for organic electroluminescence devices
12/14/2006	WO2006110884A8 2, 6-di (hetero) aryl -4-amido-pyrimidines as adenosine receptor antagonists
12/14/2006	WO2006101977A3 Pyrimidine compounds and methods of use
12/14/2006	WO2006044754A3 Process for preparing telmisartan
12/14/2006	WO2006034473A3 Novel pyrimidine compounds, process for their preparation and compositions containing them
12/14/2006	US20060281921 eg 6-[2-(dimethylamino)-1-azavinyl]-1-ethyl-3-propyl-1,3-dihydropyrimidine-2,4-dione; for making drugs for asthma and diarrhea
12/14/2006	US20060281920 such as 6-(4-ethoxy-phenyl)-2S-hydroxy-3R-[4-(3-methoxy-phenyl)-piperazine-1-carbonyl]-hexanoic acid hydroxyamide, used for the treatment or prophylaxis of arthritis in mammals
12/14/2006	US20060281796 Fused indoles as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
12/14/2006	US20060281789 Protein kinase inhibitors
12/14/2006	US20060281784 Novel benzimidazole and imidazopyridine derivatives and use thereof as a medicament
12/14/2006	US20060281782 Method for the enantioselective preparation of sulphoxide derivatives
12/14/2006	US20060281779 1 -cyclopropyl-7- [3-cyclopropylaminomethyl-4-fluoro-1 -pyrrolidinyl]-6-fluoro -1 ,4-dihydro-8-methyl-4-oxo-3-quinolinecarboxylic acid; bactericide; against drug-resistant bacteria and against gram-positive bacteria, such as MRSA, PRSP and VRE
12/14/2006	US20060281774 Pyrimidine derivatives for the treatment of abnormal cell growth
12/14/2006	US20060281772 Alkylquinoline and alkylquinazoline kinase modulators
12/14/2006	US20060281765 Such as 2-(4,6-dimethoxypyrimidine-2-ylcarbonyl)acetanilide; for use as intermediate in production of agricultural chemicals and medicines; (pyrimidine-2-yl)-2-propanonee compound reacted with hydrazine compound in the presence of an acid to produce indole compound, oxidizing, reducing, deacetylation
12/14/2006	US20060281764 Aminopyrimidines as kinase modulators
12/14/2006	US20060281763 Carboxamide inhibitors of TGFbeta
12/14/2006	US20060281761 Osteoporosis; oral diseases; bone disorders; atherosclerosis; antiarthritic agents; autoimmune disease; cachexia
12/14/2006	US20060281760 Tubulin inhibitor and process for its preparation
12/14/2006	US20060281756 Synthesis of 3-amino-4-substituted pyrazole derivatives
12/14/2006	US20060281747 1,2-di(cyclic) substituted benzene derivatives
12/14/2006	US20060281741 Therapy for bacteria infections other than Myconacterium infections; antibiotic resistance
12/14/2006	US20060281740 Bronchodilators; treating chronic obstructive pulmonary disease or asthma; long duration of action; reduced side effects, such as dry-mouth and constipation; biphenyl carbamic acid, piperidinyl ester derivatives
12/14/2006	US20060281734 3-[5-(3-acetamidobenzamido)-2-methylphenyl]-6-(4-methylpiperazin-1-yl)-3,4-dihydroquinazolin-4-one for example; treating rheumatoid arthritis, osteoarthritis, psoriasis, chronic obstructive pulmonary disease; inhibitor of cytokine-mediated disease
12/14/2006	US20060281733 4-Bromo-5-(2-chloro-benzoylamino)-1H-pyrazole-3-carboxylic acid (2-pyrrolidin-1-yl-ethyl)-amide; 5-(2-chlorobenzoylamino)-1H-pyrazole-3-carboxylic acid {2-[4-(4,5-dihydro-1H-imidazol-2-yl)-phenyl]ethyl}amide; useful for the moderation of pain, septic shock, and scarring
12/14/2006	US20060281728 3-Substituted beta-lactamyl vasopressin v1a antagonists
12/14/2006	US20060281727 (Cycloalkyleneiminocarbonyl)-indanyl- or -tetrahydronaphthyl- methylamines, e.g., {(1S)-1-[(1S)-5-(4-Fluorophenyl)-2,3-dihydro-1H-inden-1-yl]-2-[(3S)-3-fluoropyrrolidin-1-yl]-2-oxoethyl}amine hydrochloride; particularly for treating type 2 diabetes
12/14/2006	US20060281713 4-{2-[(R)-2-((E)-3-Hydroxy-4-phenyl-but-1-enyl)-6-oxo-piperidin-1-yl]-ethylsulfanyl}-butyric acid or the alkyl ester; glaucoma, intraocular hypotensive agents
12/14/2006	US20060281711 2-Morpholin-4-yl-6-(2-morpholin-4-yl-ethoxy)-pyrimidine-4-carboxylic acid (2,3-dimethyl-1H-indol-5-yl)-amide; rheumatoid arthritis, sepsis, Crohn's disease, multiple sclerosis, psoriasis, or immune-mediated diabetes mellitus
12/14/2006	US20060280688 noninvasive imaging in near-infrared (NIR) spectral range for tumor detection with a ligand-conjugated fluorescent probe
12/14/2006	US20060280687 Compounds for tissue imaging and methods of use thereof
12/14/2006	DE102005026231A1 Peptid-Deformylase (PDF) Inhibitoren 3 Peptide deformylase (PDF) inhibitors 3
12/14/2006	DE102005014936A1 New substituted oxindole derivatives are vasopressin receptor binders useful to treat e.g. diabetes insipidus, enuresis nocturna, incontinence, hypertonia, heart failure, myocardial infarction, coronary spasm and renal disorders
12/14/2006	CA2610665A1 Hydrates of alkaline-earth salts of irbesartan and the preparation thereof
12/14/2006	CA2610655A1 Cyclobutyl amine derivatives
12/14/2006	CA2610509A1 1-methyl-1h-pyrazole-4-carboxamides useful as cancer chemotherapeutic agents
12/14/2006	CA2610400A1 Azinone and diazinone v3 inhibitors for depression and stress disorders
12/14/2006	CA2610304A1 Peptide deformylase (pdf) inhibitors 4
12/14/2006	CA2608367A1 Compositions and methods for inhibition of the jak pathway
12/13/2006	EP1731519A1 Novel indole derivative for alkylating specific base sequence of dna and alkylating agent and drug each comprising the same
12/13/2006	EP1731511A1 BicyclischeI heterocycles, medicaments containing these compounds, their use and methods for the production thereof
12/13/2006	EP1731505A1 Alkoxyphenylpropanoic acid derivatives
12/13/2006	EP1730165A1 Inhibitors of hepatitis c virus ns3 protease
12/13/2006	EP1730136A1 N-piperidine derivates as ccr3 modulators
12/13/2006	EP1730134A1 Pyridine inhibitors of erk2 and uses thereof
12/13/2006	EP1730125A2 Substituted hydroxyethylamine aspartyl protease inhibitors
12/13/2006	EP1730124A1 Certain triazole-based compounds, compositions, and uses thereof
12/13/2006	EP1730122A2 Pyrimidine derivatives and methods of treatment related to the use thereof
12/13/2006	EP1730119A1 Imidazole compounds for the treatment of neurodegenerative disorders
12/13/2006	EP1730118A1 Substituted azole derivatives, compositions, and methods of use
12/13/2006	EP1730117A2 Thiourea compositions and uses thereof
12/13/2006	EP1730116A1 4-carbox pyrazole derivates useful as anti-viral agents
12/13/2006	EP1730115A1 5-aminoalkylpyrazole derivatives as pesticidal agents
12/13/2006	EP1730114A1 Benzazepine derivatives for the treatment of neurological and psychiatric disorders
12/13/2006	EP1729774A1 Pyrrolidine compounds
12/13/2006	EP1729766A1 Pharmaceutical formulation
12/13/2006	EP1385823B1 Guanidino compounds as melanocortin-4 receptor (mc4-r) agonists
12/13/2006	CN1878769A 细胞因子抑制剂 Cytokine inhibitor
12/13/2006	CN1878768A Heteroaryl deravatives as PPAR activators
12/13/2006	CN1878767A Azole-based kinase inhibitors
12/13/2006	CN1878759A Pyridazin-3 (2H) -one derivatives and their use as PDE4 inhibitors
12/13/2006	CN1876650A N-(4-bromo-2- fluorobenzene)-6-methox-7-[2(1H-1,2,3-1- triazole) ethoxy]-4-quinazoline amine hydrochloric acid synthesis and uses
12/13/2006	CN1876649A 1-(4- chloroanilino)-4-(4-methylpyridyl)-2,3-diazophenodiazine synthesis and uses
12/13/2006	CN1876648A Piperazinylpyrazine compounds as agonists or antagonists of serotonin 5ht-2 receptors
12/13/2006	CN1289486C Pyrimidine derivatives as regulating agent of insulin-like growth factor-1 receptor (igf-1)
12/13/2006	CN1289471C 3,4-di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands
12/13/2006	CN1289455C 2-(2,6-dichlorophenyl)-diarylimidazoles
12/13/2006	CN1289087C Quinoline derivatives as neuropeptide y antagonists
12/12/2006	US7148274 Heat and oxidation resistance; photostability for polymers
12/12/2006	US7148249 Indolinones substituted by heterocycles, the preparation thereof and their use as medicaments
12/12/2006	US7148242 N-formyl hydroxylamine compounds, compositions and methods of use
12/12/2006	US7148237 Nitrogen-containing heteroaryl compounds having HIV integrase inhibitory activity
12/12/2006	US7148234 Use of EP4 receptor ligands in the treatment of IL-6 involved diseases
12/12/2006	US7148221 Vanilloid receptor ligands and their use in treatments
12/12/2006	US7148220 Tyrosine kinase enzyme inhibitors as growth factor receptors and useful as antiproliferation agents
12/12/2006	US7148219 Biaryl heterocyclic compounds and methods of making and using the same
12/12/2006	CA2190851C Palladium catalyzed ring closure of triazolyl tryptamine

1 ... 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 ... 626